Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)

Clinical trial NCT03943602 · UNKNOWN

Trial details

NCT number: NCT03943602
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Penile Squamous Cell Carcinoma

Start date: 2019-08-01
Primary completion: 2022-06-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.